• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novo Nordisk A/S Common Stock (NY:NVO)

    64.85 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, May 8, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 54,867
    Open 64.85
    Bid (Size) 66.58 (6)
    Ask (Size) 66.63 (4)
    Prev. Close 64.85
    Today's Range 64.85 - 64.85
    52wk Range 57.00 - 148.15
    Shares Outstanding N/A
    Dividend Yield 3.39%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started
    Hedge funds shorting Hims & Hers Health Inc (NYSE:HIMS) may regret it - earnings with a positive surprise could lead to a short squeeze as stock continues to rise, up 96% in past month. 
    Via Benzinga
    Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
    Pharma ETFs closely watched as Trump's drug policies stir market volatility. Funds offer sector exposure but differ in risk levels and growth potential. 
    Via Benzinga
    Topics ETFs Government
    Exposures Political

    Performance

    YTD
    -25.9%
    -25.9%
    1 Month
    +5.3%
    +5.3%
    3 Month
    -25.6%
    -25.6%
    6 Month
    -39.7%
    -39.7%
    1 Year
    -48.8%
    -48.8%

    More News

    Read More
    Investors should take note of NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO), a growth stock that remains attractively priced.
    Via Chartmill
    Hims & Hers Has a Superpower in Healthcare
    Via The Motley Fool
    Earnings Scheduled For May 7, 2025
    Via Benzinga
    Down Nearly 20%: Should You Buy the Dip on Eli Lilly?
    Via The Motley Fool
    Topics Earnings Government World Trade
    Exposures Financial Political Tariff
    Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity
    Via Benzinga
    Exposures Product Safety
    Why Novo Nordisk Stock Popped After Earnings
    Via The Motley Fool
    Novo Nordisk Predicts Strong Second Half
    Via The Motley Fool
    Exposures Product Safety
    Novo Nordisk Stock Rises Pre-Market On Q1 Beat Despite Lowering Outlook – Retail’s Elated
    Via Stocktwits
    Topics Earnings Law Enforcement
    Exposures Financial Legal
    Novo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Novo Blames Compounders As It Cuts 2025 Forecast. Shares Jump.
    Via Investor's Business Daily
    Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth
    Via The Motley Fool
    Why Porch Group Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Novo Nordisk's Weight Loss Blockbuster Faces Setback From US Compounding Surge, Forecast Trimmed
    Via Benzinga
    Despite Bruce Galloway's Pushback On Bankruptcy, WeightWatchers Enters Chapter 11; Says Members Won't Be Affected
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
    Via MarketBeat
    Topics Earnings
    Exposures Financial
    Novo Nordisk's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook
    Via Investor's Business Daily
    Why Viking Therapeutics Stock Surged Nearly 20% Higher in April
    Via The Motley Fool
    Exposures Product Safety
    Hims & Hers Names New COO. Stock Rallies.
    Via Investor's Business Daily
    Topics Government Stocks World Trade
    Exposures Political Tariff US Equities
    Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery
    Via Benzinga
    3 No-Brainer Stocks to Buy in May
    Via The Motley Fool
    Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence

    Frequently Asked Questions

    Is Novo Nordisk A/S Common Stock publicly traded?
    Yes, Novo Nordisk A/S Common Stock is publicly traded.
    What exchange does Novo Nordisk A/S Common Stock trade on?
    Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Novo Nordisk A/S Common Stock?
    The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
    What is the current price of Novo Nordisk A/S Common Stock?
    The current price of Novo Nordisk A/S Common Stock is 64.85
    When was Novo Nordisk A/S Common Stock last traded?
    The last trade of Novo Nordisk A/S Common Stock was at 05/08/25 07:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.